Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sextaphag for Prevention of Ventilator-Associated Pneumonia
NCT04325685Completed
- Sponsor
- Northern State Medical University
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Randomised trial of sextaphag in ventilator-associated pneumonia (VAP) (3 arms), sponsored by Northern State Medical University. Primary endpoints: Incidence of ventilator-associated pneumonia at 14 days and Changing of oral and lung microbiomes at 14 days. Started Jan 2020; status: completed.
02
Drugs
sextaphag
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT04325685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04325685.